| Diana Lee Schrieber, CRNP | |
|
802 Landmark Dr Ste 119, Glen Burnie, MD 21061-9121 | |
| (410) 760-8484 | |
| (410) 367-2464 |
| Full Name | Diana Lee Schrieber |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 802 Landmark Dr Ste 119, Glen Burnie, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881162444 | NPI | - | NPPES |
| R187397 | Other | MD | MARYLAND BOARD OF NURSING LICENSURE |
| F10181117 | Other | MD | AANP NATIONAL CERTIFICATION |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | R192471 (Massachusetts) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | R187397 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins Regional Physicians Llc | 3274720552 | 60 |
News Archive
Takeda Pharmaceuticals North America today announced that the company has submitted a New Drug Application (NDA) for a new oral medication that combines pioglitazone HCl and glimepiride, a sulfonylurea, to the United States Food and Drug Administration (FDA) for the treatment of type 2 diabetes.
The body's immune system is an excellent weapon against many diseases. For more than 100 years, immunology and immunotherapy have played an ever-increasing role in the understanding and treatment of cancer.
Results of a randomised trial in this week's issue of THE LANCET suggest that people with type 2 diabetes could benefit from cholesterol-lowering therapy with statins to reduce the risk of cardiovascular disease, even when they do not have high cholesterol concentrations.
Having close friends and staying in contact with family members offers a protective effect against the damaging effects of Alzheimer's disease according to research by physicians at Rush University Medical Center in Chicago. The study, which is currently posted online in The Lancet Neurology, will be published in the May print edition of the journal.
Nationwide Children's Hospital and Honda announced today a $1 million gift from the automaker to establish the Honda Center for Gait Analysis and Mobility Enhancement designed to enhance pediatric mobility.
› Verified 1 days ago
| Entity Name | Johns Hopkins Regional Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609195320 PECOS PAC ID: 3274720552 Enrollment ID: O20101213000710 |
News Archive
Takeda Pharmaceuticals North America today announced that the company has submitted a New Drug Application (NDA) for a new oral medication that combines pioglitazone HCl and glimepiride, a sulfonylurea, to the United States Food and Drug Administration (FDA) for the treatment of type 2 diabetes.
The body's immune system is an excellent weapon against many diseases. For more than 100 years, immunology and immunotherapy have played an ever-increasing role in the understanding and treatment of cancer.
Results of a randomised trial in this week's issue of THE LANCET suggest that people with type 2 diabetes could benefit from cholesterol-lowering therapy with statins to reduce the risk of cardiovascular disease, even when they do not have high cholesterol concentrations.
Having close friends and staying in contact with family members offers a protective effect against the damaging effects of Alzheimer's disease according to research by physicians at Rush University Medical Center in Chicago. The study, which is currently posted online in The Lancet Neurology, will be published in the May print edition of the journal.
Nationwide Children's Hospital and Honda announced today a $1 million gift from the automaker to establish the Honda Center for Gait Analysis and Mobility Enhancement designed to enhance pediatric mobility.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diana Lee Schrieber, CRNP 802 Landmark Dr Ste 119, Glen Burnie, MD 21061-9121 Ph: (410) 760-8840 | Diana Lee Schrieber, CRNP 802 Landmark Dr Ste 119, Glen Burnie, MD 21061-9121 Ph: (410) 760-8484 |
News Archive
Takeda Pharmaceuticals North America today announced that the company has submitted a New Drug Application (NDA) for a new oral medication that combines pioglitazone HCl and glimepiride, a sulfonylurea, to the United States Food and Drug Administration (FDA) for the treatment of type 2 diabetes.
The body's immune system is an excellent weapon against many diseases. For more than 100 years, immunology and immunotherapy have played an ever-increasing role in the understanding and treatment of cancer.
Results of a randomised trial in this week's issue of THE LANCET suggest that people with type 2 diabetes could benefit from cholesterol-lowering therapy with statins to reduce the risk of cardiovascular disease, even when they do not have high cholesterol concentrations.
Having close friends and staying in contact with family members offers a protective effect against the damaging effects of Alzheimer's disease according to research by physicians at Rush University Medical Center in Chicago. The study, which is currently posted online in The Lancet Neurology, will be published in the May print edition of the journal.
Nationwide Children's Hospital and Honda announced today a $1 million gift from the automaker to establish the Honda Center for Gait Analysis and Mobility Enhancement designed to enhance pediatric mobility.
› Verified 1 days ago